Chronic Pain Among Patients With an Opioid Use Disorder.
Adolescent
Adult
Buprenorphine
/ therapeutic use
Chronic Pain
/ epidemiology
Cross-Sectional Studies
Female
Humans
Male
Methadone
/ therapeutic use
Middle Aged
Norway
/ epidemiology
Opiate Substitution Treatment
/ statistics & numerical data
Opioid-Related Disorders
/ drug therapy
Prevalence
Young Adult
Journal
The American journal on addictions
ISSN: 1521-0391
Titre abrégé: Am J Addict
Pays: England
ID NLM: 9208821
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
01
12
2020
received:
17
08
2020
accepted:
05
01
2021
pubmed:
20
3
2021
medline:
24
7
2021
entrez:
19
3
2021
Statut:
ppublish
Résumé
Chronic pain is not well understood in opioid-dependent populations. We report the prevalence of chronic pain and pain characteristics in an opioid-dependent population by treatment type and gender. This cross-sectional study opportunistically recruited 569 patients (32% women) receiving treatment for opioid use disorder (DSM-5) in Norway during 2016-2018 (83% received opioid maintenance treatment, 17% received treatment without medication). We asked about chronic pain (≥3 months; ICD-11), pain severity (NRS-11), and other pain characteristics. Overall, 55% reported chronic pain (≥3 months), with a higher prevalence among women (61% vs 52%, P = .041) and patients receiving methadone (66%) compared with buprenorphine or no medication (46% and 45%, P < .001). Chronic pain was associated with higher age (P < .001) and higher doses of methadone (P = .048). The average duration of pain was 11 years. The most frequently reported pain locations were the lower extremities (59%) and the back (54%), and 69% reported more than one pain location. Constant pain and migrating pain were significantly associated with both moderate (adjusted odds ratio [aOR]: 2.04, confidence interval [CI]: 1.12-3.74 and aOR: 2.44, CI: 1.09-5.43) and severe pain intensity (aOR: 2.08, CI: 1.14-3.80 and aOR: 2.46, CI: 1.10-5.47). Reporting no effect of analgesics was associated with severe pain intensity (aOR: 0.54, CI: 0.29-0.99). Over half reported chronic pain, and rates were highest among women and patients receiving methadone. New contributions to the field are descriptions of pain characteristics by gender and pain severity, and interactions between medication type and age. (© 2021 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry). (Am J Addict 2021;00:00-00).
Sections du résumé
BACKGROUND AND OBJECTIVES
Chronic pain is not well understood in opioid-dependent populations. We report the prevalence of chronic pain and pain characteristics in an opioid-dependent population by treatment type and gender.
METHODS
This cross-sectional study opportunistically recruited 569 patients (32% women) receiving treatment for opioid use disorder (DSM-5) in Norway during 2016-2018 (83% received opioid maintenance treatment, 17% received treatment without medication). We asked about chronic pain (≥3 months; ICD-11), pain severity (NRS-11), and other pain characteristics.
RESULTS
Overall, 55% reported chronic pain (≥3 months), with a higher prevalence among women (61% vs 52%, P = .041) and patients receiving methadone (66%) compared with buprenorphine or no medication (46% and 45%, P < .001). Chronic pain was associated with higher age (P < .001) and higher doses of methadone (P = .048). The average duration of pain was 11 years. The most frequently reported pain locations were the lower extremities (59%) and the back (54%), and 69% reported more than one pain location. Constant pain and migrating pain were significantly associated with both moderate (adjusted odds ratio [aOR]: 2.04, confidence interval [CI]: 1.12-3.74 and aOR: 2.44, CI: 1.09-5.43) and severe pain intensity (aOR: 2.08, CI: 1.14-3.80 and aOR: 2.46, CI: 1.10-5.47). Reporting no effect of analgesics was associated with severe pain intensity (aOR: 0.54, CI: 0.29-0.99).
CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE
Over half reported chronic pain, and rates were highest among women and patients receiving methadone. New contributions to the field are descriptions of pain characteristics by gender and pain severity, and interactions between medication type and age. (© 2021 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry). (Am J Addict 2021;00:00-00).
Substances chimiques
Buprenorphine
40D3SCR4GZ
Methadone
UC6VBE7V1Z
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
366-375Informations de copyright
© 2021 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry (AAAP).
Références
Potter JS , Shiffman SJ , Weiss RD . Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse. 2008;34:101-107.
Barry DT , Savant JD , Beitel M , et al. Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study. Am J Addict. 2013;22:212-217.
Peles E , Schreiber S , Gordon J , et al. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113:340-346.
Rosenblum A , Joseph H , Fong C , et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370-2378.
Dunn KE , Finan PH , Tompkins DA , et al. Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug Alcohol Depend. 2015;157:143-149.
Peles E , Schreiber S , Adelson M . Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol. 2009;19:581-588.
Stein MD , Herman DS , Bailey GL , et al. Chronic pain and depression among primary care patients treated with buprenorphine. J Gen Intern Med. 2015;30:935-941.
Breivik H , Collett B , Ventafridda V , et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287.
Johannes CB , Le TK , Zhou X , et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11:1230-1239.
Dahlhamer J , Lucas J , Zelaya C , et al. Prevalence of chronic pain and high-impact chronic pain among adults-United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67:1001-1006.
Pud D , Cohen D , Lawental E , et al. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend. 2006;82:218-223.
Phillips K , Clauw DJ . Central pain mechanisms in chronic pain states-maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25:141-154.
Baron MJ , McDonald PW . Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag. 2006;2:277-282.
Latif ZH , Solli KK , Opheim A , et al. No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: a 3-month randomized study and 9-month open-treatment follow-up study. Am J Addict. 2019;28:77-85.
Dhingra L , Masson C , Perlman DC , et al. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013;128:161-165.
Barry DT , Beitel M , Cutter CJ , et al. Exploring relations among traumatic, posttraumatic, and physical pain experiences in methadone-maintained patients. J Pain. 2011;12:22-28.
Barry DT , Beitel M , Garnet B , et al. Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry. 2009;70:1213-1218.
Nordmann S , Vilotitch A , Lions C , et al. Pain in methadone patients: time to address undertreatment and suicide risk (ANRS-Methaville trial). PLOS One. 2017;12:e0176288.
Rustøen T , Wahl AK , Hanestad BR , et al. Gender differences in chronic pain-findings from a population-based study of Norwegian adults. Pain Manag Nurs. 2004;5:105-117.
Larson MJ , Paasche-Orlow M , Cheng DM , et al. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007;102:752-760.
Karasz A , Zallman L , Berg K , et al. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage. 2004;28:517-525.
Li F , Xu Y-M , Zhu J-H , et al. Pain of methadone-maintained heroin addicts: lonelier individuals feel more intense pain. Oncotarget. 2017;8:79948-79952.
Waal H, Bussesund K, Clausen T, et al. The Annual OMT Status Survey for 2018 (Statusrapport 2018-LAR i rusreformenes tid). Oslo, Norway: Norwegian Center for Addiction Research; 2019 (in Norwegian).
Pud D , Zlotnick C , Lawental E . Pain depression and sleep disorders among methadone maintenance treatment patients. Addict Behav. 2012;37:1205-1210.
Hjermstad MJ , Fayers PM , Haugen DF , et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011;41:1073-1093.
Streiner DL , Norman GR . Correction for multiple testing: is there a resolution? Chest. 2011;140:16-18.
Rustøen T , Wahl AK , Hanestad BR , et al. Prevalence and characteristics of chronic pain in the general Norwegian population. Eur J Pain. 2004;8:555-565.
Fillingim RB , King CD , Ribeiro-Dasilva MC , et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447-485.
Hser Y-I , Mooney LJ , Saxon AJ , et al. Chronic pain among patients with opioid use disorder: results from electronic health records data. J Subst Abuse Treat. 2017;77:26-30.
Edwards RR , Fillingim RB , Ness TJ . Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain. 2003;101:155-165.
Dennis BB , Samaan MC , Bawor M , et al. Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat. 2014;10:2239-2247.
Larney S , Peacock A , Mathers BM , et al. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39-49.
Massaly N , Morón JA , Al-Hasani R . A trigger for opioid misuse: chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system. Front Neurosci. 2016;10:480.
Hadjimichael O , Kerns RD , Rizzo MA , et al. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007;127:35-41.
Stein C , Schäfer M , Machelska H . Attacking pain at its source: new perspectives on opioids. Nature Med. 2003;9:1003-1008.